|
|
Build Your Online Product Catalogs?
| Product Name: |
5% glucose injection
|
| Supply Ability: |
400 million |
| Related proudcts |
gmp, dextrose, |
| Specifications |
500ml,250ml,100ml |
| Price Term: |
FOB |
| Port of loading: |
TIANJIN |
| Minimum Order |
20000 |
| Unit Price: |
0.260USD |
|
Product Name: Dextrose Injection 5% ,Glucose Injection5%,Dextrose infusion 5%,Glucose infusion 10%
Product Description : A clear, colourless or almost colourless liquid,taste sweet.
Strength: 5g/100ml,12.5g/250ml,25g/500ml
INN or Generic Name: Hydrous Dextrose
Pharmaceutical Dosage Form: injection
Packing:butyl rubber stopper and aluminium cap,polypropylene bottle
Carton packing:
(1)500ml: 30PCS/CTN,713 CTNS/20'FT,1532CTNS /40'FT,1796CTNS /40'HQ
(2)250ml: 30PCS/CTN,1082 CTNS/20'FT,2324 CTNS /40'FT,2725 CTNS /40'HQ
(3)100ml: 80PCS/CTN,726 CTNS/20'FT,1559 CTNS/40'FT,1828 CTNS/40'HQ
Port: Any port (depends on requests) Certificate:GMP
Exporting Region: Areas which GMP is applicable
Therapeutic indications
Intravenous solutions containing Dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient.
Posology and method of administration
The dose is dependent upon the age, weight and clinical condition of the patient.
As reported in the literature, the dosage and constant infusion rate of intravenous Dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.
Drug Interactions
Additives may be inco***tible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.
Contraindications:
5% Dextrose Injection, USP without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.
Special warning and precautions for use:
Warnings
Excessive administration of potassium-free solutions may result in |
| Company: |
Hebei Tiancheng pharmaceutical co., ltd
|
| Contact: |
Ms. Grace Zhang |
| Address: |
NO.18,Jinguang Street, Economic & Technological Development Zone, Cangzhou, Hebei, China. |
| Postcode: |
061000 |
| Tel: |
86-317-7883289 |
| Fax: |
86-317-7883066 |
| E-mail: |
|
|
|
|
Home
